RESOLIAN

WIPO WIPO 2023

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The International trademark RESOLIAN was filed as Word mark on 03/31/2023 at the World Intellectual Property Organization.

Trademark Details Last update: August 3, 2023

Trademark form Word mark
File reference 1728904
Countries Australia China em United Kingdom
Base trademark US No. 97796226, February 15, 2023
Application date March 31, 2023
Expiration date March 31, 2033

Trademark owner

Great Valley Corporate Center,
17 Lee Boulevard
US

Trademark representatives

997 Lenox Drive, Bldg. 3 Lawrenceville NJ 08648-2311 US

goods and services

42 Laboratory testing services in clinical research and clinical trials of innovator and generic medicines in the pharmaceutical and biotechnology fields; research and development in the fields of bioanalysis, immunoassay development, validation and testing, biomarker studies, drug metabolism, and pharmacokinetic testing; pharmaceutical research and development services; chemical, bioanalytical, biological and biotechnology research services; research and development in the pharmaceutical and biotechnology fields; research and development of vaccines and medicines; pharmaceutical drug development services; scientific testing for medical and pharmaceutical research purposes; drug and chemical materials analysis services, namely, quality evaluation and analysis, quality assurance, and quality control, in the fields of pharmaceutical, biopharmaceutical, biotechnology and medical device development; operating and maintaining a biorepository for medical and scientific research purposes; laboratory services; Good Manufacturing Practices (GMP) laboratory and stability testing and analytical services in the fields of pharmaceutical drug, pharmaceutical excipient, and consumer healthcare chemical development; Chemistry, Manufacturing, and Controls (CMC) laboratory and stability testing and analytical services in the fields of pharmaceutical drug, pharmaceutical excipient, and consumer healthcare chemical development; analytical services, namely, providing Good Laboratory Practices (GLP) testing and quality assurance services to assess clinical performance in the field of therapeutic drug evaluation and development

Trademark history

Date Document number Area Entry
August 2, 2023 2023/31 Gaz GB Rejection
March 31, 2023 2023/17 Gaz US Registration

ID: 141728904